TY - JOUR
T1 - Multidisciplinary approach achieves limb salvage without revascularization in patients with mild to moderate ischemia and tissue loss
AU - Gabel, Joshua
AU - Bianchi, Christian
AU - Possagnoli, Isabella
AU - Mehta, Rittal
AU - Abou-Zamzam, Ahmed M.
AU - Teruya, Theodore
AU - Kiang, Sharon
AU - Bishop, Vicki
AU - Valenzuela, Adela
N1 - Publisher Copyright:
© 2019 Society for Vascular Surgery
PY - 2020/6
Y1 - 2020/6
N2 - Objective: The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system has been validated to predict wound healing and limb salvage of patients with peripheral artery disease (PAD). Our goal was to evaluate the association between WIfI stage and wound healing, limb salvage, and survival in a select cohort of patients with PAD and tissue loss undergoing an attempt of wound healing without immediate revascularization (conservative approach) in a multidisciplinary wound program. Methods: Veterans with PAD and tissue loss were prospectively enrolled in our Prevention of Amputation in Veterans Everywhere (PAVE) program. Limbs were stratified to a conservative, revascularization, primary amputation, and palliative limb care approach based on the patient's fitness, ambulatory status, perfusion evaluation, and validated pathway of care. Rates of wound healing, wound recurrence, limb salvage, and survival were retrospectively analyzed by WIfI clinical stages (stage 1-4) in the conservative group. Cox regression modeling was used to estimate clinical outcomes by WIfI stage. Results: Between January 2006 and October 2017, there were 961 limbs prospectively enrolled in our PAVE program. A total of 233 limbs with 277 wounds were stratified to the conservative approach. WIfI staging distribution included 19.7% stage 1, 20.2% stage 2, 38.6% stage 3, and 21.5% stage 4. All ischemia scores were classified as 1 or 2. Advanced wound interventions and minor amputations were performed on 40 limbs (16.6%) and 57 limbs (23.7%), respectively. Average long-term follow-up was 41.4 ± 29.0 months. Complete wound healing without revascularization was achieved in 179 limbs (76.8%) during 4.4 ± 4.1 months. Thirty-four limbs (14%) underwent deferred revascularization because of a lack of complete wound healing. At long-term follow-up, wound recurrence per limb was 39%. Overall limb salvage at long-term follow-up was 89.3%. Stratified by WIfI stage, there was no statistically significant difference between groups for wound healing (P =.64), wound recurrence (P =.55), or limb salvage (P =.66) after adjustment for significant patient, limb, and wound characteristics. Conclusions: In select patients with mild to moderate ischemia and tissue loss, a stratified approach can achieve acceptable rates of wound healing and limb salvage, with limited need for deferred revascularization. WIfI clinical staging did not predict wound healing, limb salvage, or survival in this cohort.
AB - Objective: The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system has been validated to predict wound healing and limb salvage of patients with peripheral artery disease (PAD). Our goal was to evaluate the association between WIfI stage and wound healing, limb salvage, and survival in a select cohort of patients with PAD and tissue loss undergoing an attempt of wound healing without immediate revascularization (conservative approach) in a multidisciplinary wound program. Methods: Veterans with PAD and tissue loss were prospectively enrolled in our Prevention of Amputation in Veterans Everywhere (PAVE) program. Limbs were stratified to a conservative, revascularization, primary amputation, and palliative limb care approach based on the patient's fitness, ambulatory status, perfusion evaluation, and validated pathway of care. Rates of wound healing, wound recurrence, limb salvage, and survival were retrospectively analyzed by WIfI clinical stages (stage 1-4) in the conservative group. Cox regression modeling was used to estimate clinical outcomes by WIfI stage. Results: Between January 2006 and October 2017, there were 961 limbs prospectively enrolled in our PAVE program. A total of 233 limbs with 277 wounds were stratified to the conservative approach. WIfI staging distribution included 19.7% stage 1, 20.2% stage 2, 38.6% stage 3, and 21.5% stage 4. All ischemia scores were classified as 1 or 2. Advanced wound interventions and minor amputations were performed on 40 limbs (16.6%) and 57 limbs (23.7%), respectively. Average long-term follow-up was 41.4 ± 29.0 months. Complete wound healing without revascularization was achieved in 179 limbs (76.8%) during 4.4 ± 4.1 months. Thirty-four limbs (14%) underwent deferred revascularization because of a lack of complete wound healing. At long-term follow-up, wound recurrence per limb was 39%. Overall limb salvage at long-term follow-up was 89.3%. Stratified by WIfI stage, there was no statistically significant difference between groups for wound healing (P =.64), wound recurrence (P =.55), or limb salvage (P =.66) after adjustment for significant patient, limb, and wound characteristics. Conclusions: In select patients with mild to moderate ischemia and tissue loss, a stratified approach can achieve acceptable rates of wound healing and limb salvage, with limited need for deferred revascularization. WIfI clinical staging did not predict wound healing, limb salvage, or survival in this cohort.
KW - CLTI
KW - Multidisciplinary
KW - PAD
KW - Revascularization
KW - WIfI
KW - Wound
KW - Recurrence
KW - Risk Assessment
KW - United States
KW - Humans
KW - Ischemia/diagnosis
KW - Middle Aged
KW - Risk Factors
KW - Male
KW - Treatment Outcome
KW - Amputation, Surgical
KW - Wound Healing
KW - Veterans Health
KW - Peripheral Arterial Disease/diagnosis
KW - Time Factors
KW - Aged
KW - Retrospective Studies
KW - Limb Salvage/adverse effects
KW - Vascular Patency
UR - http://www.scopus.com/inward/record.url?scp=85075503807&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075503807&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/544ad738-56df-3d89-9010-b27aa5d3f560/
U2 - 10.1016/j.jvs.2019.07.103
DO - 10.1016/j.jvs.2019.07.103
M3 - Article
C2 - 31727460
SN - 0741-5214
VL - 71
SP - 2073-2080.e1
JO - Journal of Vascular Surgery
JF - Journal of Vascular Surgery
IS - 6
ER -